RESEARCH: CANCER
FOLDING PROJECT #16953 PROFILE

This project relates to understanding how small proteins fold. We're looking at how things like chemical bonds and slight changes in the protein's code affect how it folds. This could help us design better drugs, like those that target cancer cells.

Note: This TLDR is a simplication and may not be 100% accurate.

These simulations are designed to test our understanding the folding mechanism of alpha-helical hairpins.

We are trying to study how disulfide cross-linkers and sequence variants affect the folding thermodynamics and kinetics of these proteins, to learn how we might better use molecular simulation methods to design effective protein binder scaffolds, for use as "affibody" cancer therapeutics, for example.

---

alpha-helical hairpins

Secondary structure in proteins characterized by an alpha helix.

Alpha-helical hairpins are small protein segments with a distinct curved shape formed by alpha helices. These structures play a role in protein folding and stability.

---

disulfide cross-linkers

Covalent bonds formed between cysteine amino acids in proteins.

Disulfide cross-linkers are strong chemical bonds that connect two cysteine amino acids within a protein. They contribute to protein stability and shape.

---

sequence variants

Alterations in the DNA sequence of a gene.

Sequence variants are changes in the order of DNA building blocks (nucleotides) within a gene. These variations can lead to altered protein production and function.

---

folding thermodynamics

The energy changes associated with protein folding.

Folding thermodynamics describes the energy required for proteins to adopt their correct three-dimensional shape. This process is influenced by various factors, including chemical interactions and environmental conditions.

---

folding kinetics

The rate of protein folding.

Folding kinetics refers to how quickly proteins transition from a disordered state to their functional, folded form. This process can be influenced by factors like temperature and the presence of chaperone molecules.

---

protein binder scaffolds

Structural frameworks that can be designed to bind specific target molecules.

Protein binder scaffolds are engineered protein structures that serve as templates for creating drugs. These scaffolds can be modified to specifically recognize and bind to desired targets, such as disease-related proteins.

---

affibody

A type of engineered protein binder.

Affibody is a shorthand term for an affibody molecule, which is a small, stable protein that binds to specific target molecules. They are often used in research and drug development due to their high affinity and specificity.

---

cancer therapeutics

Medications used to treat cancer.

Cancer therapeutics encompass a wide range of treatments designed to combat the growth and spread of cancerous cells. These include chemotherapy, radiation therapy, immunotherapy, and targeted therapies.